Top Key Companies for Cell and Gene Therapy Market: Novartis AG, CHIESI Farmaceutici, GC Pharma, Biosolution, Organogenesis, Spark Therapeutics, AnGes, CO.DON, Takeda Pharmaceutical Company, Amgen, AVITA Medical, APAC Biotech, Vericel, Dendreon, JCR Pharmaceuticals, Corestem, Orchard Therapeutics, Osiris Therapeutics, Japan Tissue Engineering, Medipost, Gilead Sciences, CollPlant, MolMed, Stempeutics Research, JW CreaGene, Tego Sciences.
Global Cell and Gene Therapy Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Cell and Gene Therapy Market Overview And Scope:
The Global Cell and Gene Therapy Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Cell and Gene Therapy utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Global Cell and Gene Therapy Market Segmentation
By Type, Cell and Gene Therapy market has been segmented into:
Cell Therapy
Gene Therapy
By Application, Cell and Gene Therapy market has been segmented into:
Hospitals
Wound Care Centers
Cancer Care Centers
Ambulatory Surgical Centers
Others
Regional Analysis of Cell and Gene Therapy Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Cell and Gene Therapy Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Cell and Gene Therapy market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Cell and Gene Therapy market.
Top Key Companies Covered in Cell and Gene Therapy market are:
Novartis AG
CHIESI Farmaceutici
GC Pharma
Biosolution
Organogenesis
Spark Therapeutics
AnGes
CO.DON
Takeda Pharmaceutical Company
Amgen
AVITA Medical
APAC Biotech
Vericel
Dendreon
JCR Pharmaceuticals
Corestem
Orchard Therapeutics
Osiris Therapeutics
Japan Tissue Engineering
Medipost
Gilead Sciences
CollPlant
MolMed
Stempeutics Research
JW CreaGene
Tego Sciences
Key Questions answered in the Cell and Gene Therapy Market Report:
1. What is the expected Cell and Gene Therapy Market size during the forecast period, 2025-2032?
2. Which region is the largest market for the Cell and Gene Therapy Market?
3. What is the expected future scenario and the revenue generated by different regions and countries in the Cell and Gene Therapy Market, such as North America, Europe, AsiaPacific & Japan, China, U.K., South America, and Middle East and Africa?
4. What is the competitive strength of the key players in the Cell and Gene Therapy Market on the basis of the analysis of their recent developments, product offerings, and regional presence?
5. Where do the key Cell and Gene Therapy companies lie in their competitive benchmarking compared to the factors of market coverage and market potential?
6. How are the adoption scenario, related opportunities, and challenges impacting the Cell and Gene Therapy Markets?
7. How is the funding and investment landscape in the Cell and Gene Therapy Market?
8. Which are the leading consortiums and associations in the Cell and Gene Therapy Market, and what is their role in the market?
Research Methodology for Cell and Gene Therapy Market Report:
The report presents a detailed assessment of the Cell and Gene Therapy Market, along with qualitative inputs and insights from Company. This research study involved the extensive use of both primary and secondary sources.Various factors affecting the industry were studied to identify the segmentation types; industry trends; key players; competitive landscape of different products and services provided by separate market players;key market dynamics, such as drivers, restraints, opportunities, challenges, and industry trends; and key player strategies. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights.Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Cell and Gene Therapy Market by Type
5.1 Cell and Gene Therapy Market Overview Snapshot and Growth Engine
5.2 Cell and Gene Therapy Market Overview
5.3 Cell Therapy
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Cell Therapy: Geographic Segmentation
5.4 Gene Therapy
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Gene Therapy: Geographic Segmentation
Chapter 6: Cell and Gene Therapy Market by Application
6.1 Cell and Gene Therapy Market Overview Snapshot and Growth Engine
6.2 Cell and Gene Therapy Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation
6.4 Wound Care Centers
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Wound Care Centers: Geographic Segmentation
6.5 Cancer Care Centers
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Cancer Care Centers: Geographic Segmentation
6.6 Ambulatory Surgical Centers
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Ambulatory Surgical Centers: Geographic Segmentation
6.7 Others
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2017-2032F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Cell and Gene Therapy Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Cell and Gene Therapy Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Cell and Gene Therapy Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 NOVARTIS AG
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 CHIESI FARMACEUTICI
7.4 GC PHARMA
7.5 BIOSOLUTION
7.6 ORGANOGENESIS
7.7 SPARK THERAPEUTICS
7.8 ANGES
7.9 CO.DON
7.10 TAKEDA PHARMACEUTICAL COMPANY
7.11 AMGEN
7.12 AVITA MEDICAL
7.13 APAC BIOTECH
7.14 VERICEL
7.15 DENDREON
7.16 JCR PHARMACEUTICALS
7.17 CORESTEM
7.18 ORCHARD THERAPEUTICS
7.19 OSIRIS THERAPEUTICS
7.20 JAPAN TISSUE ENGINEERING
7.21 MEDIPOST
7.22 GILEAD SCIENCES
7.23 COLLPLANT
7.24 MOLMED
7.25 STEMPEUTICS RESEARCH
7.26 JW CREAGENE
7.27 TEGO SCIENCES
Chapter 8: Global Cell and Gene Therapy Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Cell Therapy
8.2.2 Gene Therapy
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospitals
8.3.2 Wound Care Centers
8.3.3 Cancer Care Centers
8.3.4 Ambulatory Surgical Centers
8.3.5 Others
Chapter 9: North America Cell and Gene Therapy Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Cell Therapy
9.4.2 Gene Therapy
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospitals
9.5.2 Wound Care Centers
9.5.3 Cancer Care Centers
9.5.4 Ambulatory Surgical Centers
9.5.5 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Cell and Gene Therapy Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Cell Therapy
10.4.2 Gene Therapy
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospitals
10.5.2 Wound Care Centers
10.5.3 Cancer Care Centers
10.5.4 Ambulatory Surgical Centers
10.5.5 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Cell and Gene Therapy Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Cell Therapy
11.4.2 Gene Therapy
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospitals
11.5.2 Wound Care Centers
11.5.3 Cancer Care Centers
11.5.4 Ambulatory Surgical Centers
11.5.5 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Cell and Gene Therapy Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Cell Therapy
12.4.2 Gene Therapy
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospitals
12.5.2 Wound Care Centers
12.5.3 Cancer Care Centers
12.5.4 Ambulatory Surgical Centers
12.5.5 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Cell and Gene Therapy Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Cell Therapy
13.4.2 Gene Therapy
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospitals
13.5.2 Wound Care Centers
13.5.3 Cancer Care Centers
13.5.4 Ambulatory Surgical Centers
13.5.5 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Cell and Gene Therapy Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Cell Therapy
14.4.2 Gene Therapy
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospitals
14.5.2 Wound Care Centers
14.5.3 Cancer Care Centers
14.5.4 Ambulatory Surgical Centers
14.5.5 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Cell and Gene Therapy Scope:
|
Report Data
|
Cell and Gene Therapy Market
|
|
Cell and Gene Therapy Market Size in 2025
|
USD XX million
|
|
Cell and Gene Therapy CAGR 2025 - 2032
|
XX%
|
|
Cell and Gene Therapy Base Year
|
2024
|
|
Cell and Gene Therapy Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Novartis AG, CHIESI Farmaceutici, GC Pharma, Biosolution, Organogenesis, Spark Therapeutics, AnGes, CO.DON, Takeda Pharmaceutical Company, Amgen, AVITA Medical, APAC Biotech, Vericel, Dendreon, JCR Pharmaceuticals, Corestem, Orchard Therapeutics, Osiris Therapeutics, Japan Tissue Engineering, Medipost, Gilead Sciences, CollPlant, MolMed, Stempeutics Research, JW CreaGene, Tego Sciences.
|
|
Key Segments
|
By Type
Cell Therapy Gene Therapy
By Applications
Hospitals Wound Care Centers Cancer Care Centers Ambulatory Surgical Centers Others
|